Holdings
Parkman Healthcare Partners LLC
As of Sep 30, 2026, Parkman Healthcare Partners LLC reported 88 positions worth US$1.07B. Largest: PTC Therapeutics, Inc., Eli Lilly and Company and MBX Biosciences, Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 88
- Value as reported
- US$1.07B
- Holdings as of
- Sep 30, 2026
- Last filed
- Nov 16, 2026
| Company | Shares | Value as reported | % of company | % of portfolio | Change | As of |
|---|---|---|---|---|---|---|
| PTC Therapeutics, Inc. NASDAQ:PTCT | 700K | US$45.4M | 4.1% | +265K | Sep 30, 2026 | |
| Eli Lilly and Company NYSE:LLY | 38,119 | US$44.1M | <0.01% | 4.0% | +3,119 | Sep 30, 2026 |
| MBX Biosciences, Inc. NASDAQ:MBX | 717K | US$42M | 3.8% | −83,631 | Sep 30, 2026 | |
| IQVIA Holdings, Inc. NYSE:IQV | 145K | US$39M | 0.09% | 3.5% | +39,410 | Sep 30, 2026 |
| DexCom, Inc. NASDAQ:DXCM | 437K | US$37.7M | 0.12% | 3.4% | −97,733 | Sep 30, 2026 |
| Inhibrx Biosciences, Inc. NASDAQ:INBX | 360K | US$36.1M | 2.4% | 3.2% | +103K | Sep 30, 2026 |
| Viridian Therapeutics, Inc. NASDAQ:VRDN | 1.67M | US$34.5M | 3.1% | +297K | Sep 30, 2026 | |
| Scholar Rock Holding Corporation NASDAQ:SRRK | 540K | US$26.1M | 2.4% | New | Sep 30, 2026 | |
| CVS Health Corporation NYSE:CVS | 286K | US$24.5M | 0.02% | 2.2% | −106K | Sep 30, 2026 |
| Alto Neuroscience, Inc. NYSE:ANRO | 949K | US$24.2M | 2.4% | 2.2% | +520K | Sep 30, 2026 |
| Agios Pharmaceuticals, Inc. NASDAQ:AGIO | 633K | US$21.1M | 1.9% | −35,734 | Sep 30, 2026 | |
| Syndax Pharmaceuticals, Inc. NASDAQ:SNDX | 1.11M | US$20.8M | 1.9% | +228K | Sep 30, 2026 | |
| UnitedHealth Group Incorporated NYSE:UNH | 55,871 | US$20.5M | <0.01% | 1.8% | −50 | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. NASDAQ:AMLX | 675K | US$19.6M | 1.8% | +276K | Sep 30, 2026 | |
| Assembly Biosciences, Inc. NASDAQ:ASMB | 796K | US$18.7M | 3.9% | 1.7% | +75,075 | Sep 30, 2026 |
| Indivior Pharmaceuticals, Inc. NASDAQ:INDV | 522K | US$18.7M | 1.7% | +157K | Sep 30, 2026 | |
| Charles River Laboratories International, Inc. NYSE:CRL | 60,000 | US$17.7M | 1.6% | New | Sep 30, 2026 | |
| Kodiak Sciences Inc NASDAQ:KOD | 186K | US$17.6M | 0.28% | 1.6% | New | Sep 30, 2026 |
| Arcus Biosciences, Inc. NYSE:RCUS | 676K | US$17.4M | 0.47% | 1.6% | −244K | Sep 30, 2026 |
| Adaptive Biotechnologies Corporation NASDAQ:ADPT | 600K | US$17.3M | 1.6% | +113K | Sep 30, 2026 | |
| Tarsus Pharmaceuticals, Inc. NASDAQ:TARS | 213K | US$16.8M | 1.5% | +63,395 | Sep 30, 2026 | |
| Abbott Laboratories NYSE:ABT | 165K | US$16.3M | <0.01% | 1.5% | New | Sep 30, 2026 |
| Tenet Healthcare Corporation NYSE:THC | 63,854 | US$16.3M | 0.08% | 1.5% | −33,426 | Sep 30, 2026 |
| Xeris Biopharma Holdings, Inc. NASDAQ:XERS | 1.64M | US$15.7M | 0.90% | 1.4% | −165K | Sep 30, 2026 |
| Cyberonics Inc | 196K | US$15M | 1.3% | New | Sep 30, 2026 | |
| West Pharmaceutical Services, Inc. NYSE:WST | 40,000 | US$14.8M | 0.06% | 1.3% | New | Sep 30, 2026 |
| Avalo Therapeutics, Inc. NASDAQ:AVTX | 929K | US$14.2M | 1.3% | +163K | Sep 30, 2026 | |
| Aveanna Healthcare Holdings Inc. NASDAQ:AVAH | 1.13M | US$14M | 0.52% | 1.3% | +412K | Sep 30, 2026 |
| Shoulder Innovations, Inc. NYSE:SI | 727K | US$13.7M | 3.5% | 1.2% | +501K | Sep 30, 2026 |
| ANI Pharmaceuticals, Inc. NASDAQ:ANIP | 186K | US$13.5M | 1.2% | −17,052 | Sep 30, 2026 | |
| Edgewise Therapeutics, Inc. NASDAQ:EWTX | 328K | US$13.3M | 1.2% | −249K | Sep 30, 2026 | |
| Castle Biosciences, Inc. NASDAQ:CSTL | 368K | US$13.1M | 1.2% | 1.2% | +223K | Sep 30, 2026 |
| CareDx, Inc. NASDAQ:CDNA | 200K | US$13M | 0.38% | 1.2% | −2,007 | Sep 30, 2026 |
| AtriCure, Inc. NASDAQ:ATRC | 225K | US$12.7M | 1.1% | New | Sep 30, 2026 | |
| Waters Corporation NYSE:WAT | 27,878 | US$12.2M | 0.03% | 1.1% | −2,328 | Sep 30, 2026 |
| Insmed Incorporated NASDAQ:INSM | 105K | US$12M | 0.05% | 1.1% | New | Sep 30, 2026 |
| CryoPort, Inc. NASDAQ:CYRX | 679K | US$11.8M | 1.3% | 1.1% | +170K | Sep 30, 2026 |
| Schrodinger, Inc. NASDAQ:SDGR | 375K | US$11.6M | 0.57% | 1.0% | New | Sep 30, 2026 |
| 4D Molecular Therapeutics, Inc. NASDAQ:FDMT | 772K | US$11M | 1.00% | −176K | Sep 30, 2026 | |
| Carlsmed, Inc. NASDAQ:CARL | 780K | US$11M | 2.8% | 0.99% | +182K | Sep 30, 2026 |
| Hemab Therapeutics Holdings, Inc. NASDAQ:COAG | 329K | US$10.2M | 0.70% | 0.91% | +284K | Sep 30, 2026 |
| iRhythm Holdings, Inc. NASDAQ:IRTC | 85,743 | US$9.75M | 0.88% | +18,476 | Sep 30, 2026 | |
| Inspire Medical Systems, Inc. NYSE:INSP | 130K | US$9.02M | 0.81% | New | Sep 30, 2026 | |
| Tempus AI, Inc. NASDAQ:TEM | 110K | US$9.01M | 0.06% | 0.81% | New | Sep 30, 2026 |
| Nuvectis Pharma, Inc. NASDAQ:NVCT | 425K | US$8.98M | 1.2% | 0.81% | New | Sep 30, 2026 |
| Structure Therapeutics, Inc. NASDAQ:GPCR | 284K | US$8.87M | 0.13% | 0.80% | New | Sep 30, 2026 |
| Cogent Biosciences, Inc. NASDAQ:COGT | 276K | US$8.83M | 0.80% | +22,470 | Sep 30, 2026 | |
| Alnylam Pharmaceuticals, Inc. NASDAQ:ALNY | 35,159 | US$8.68M | 0.78% | −15,513 | Sep 30, 2026 | |
| Supernus Pharmaceuticals, Inc. NASDAQ:SUPN | 200K | US$8.61M | 0.34% | 0.78% | New | Sep 30, 2026 |
| Immunome, Inc. NASDAQ:IMNM | 396K | US$8.53M | 0.77% | −198K | Sep 30, 2026 | |
| Mineralys Therapeutics, Inc. NASDAQ:MLYS | 314K | US$7.89M | 0.71% | −66,339 | Sep 30, 2026 | |
| Viatris Inc. NASDAQ:VTRS | 443K | US$7.85M | 0.04% | 0.71% | +243K | Sep 30, 2026 |
| Insulet Corporation NASDAQ:PODD | 59,912 | US$7.82M | 0.70% | −71,466 | Sep 30, 2026 | |
| Xenon Pharmaceuticals Inc. NASDAQ:XENE | 208K | US$7.74M | 0.70% | −189K | Sep 30, 2026 | |
| Exagen Inc. NASDAQ:XGN | 927K | US$7.53M | 3.6% | 0.68% | New | Sep 30, 2026 |
| Teleflex Incorporated NYSE:TFX | 60,000 | US$7.5M | 0.68% | New | Sep 30, 2026 | |
| SI-BONE, Inc. NASDAQ:SIBN | 393K | US$7.38M | 0.67% | +64,117 | Sep 30, 2026 | |
| Bright Minds Biosciences Inc. CSE:DRUG | 148K | US$7.38M | 1.5% | 0.67% | −56,826 | Sep 30, 2026 |
| Vericel Corporation NASDAQ:VCEL | 180K | US$7.24M | 0.65% | New | Sep 30, 2026 | |
| Stoke Therapeutics, Inc. NASDAQ:STOK | 267K | US$6.94M | 0.63% | −88,460 | Sep 30, 2026 | |
| Envista Holdings Corporation NYSE:NVST | 281K | US$6.6M | 0.59% | −273K | Sep 30, 2026 | |
| MiniMed Group, Inc. NASDAQ:MMED | 321K | US$6.26M | 0.11% | 0.56% | +95,053 | Sep 30, 2026 |
| Vir Biotechnology, Inc. NASDAQ:VIR | 517K | US$5.78M | 0.30% | 0.52% | +42,098 | Sep 30, 2026 |
| Climb Bio, Inc. NASDAQ:CLYM | 468K | US$5.37M | 0.48% | −95,276 | Sep 30, 2026 | |
| Precision BioSciences, Inc. NASDAQ:DTIL | 837K | US$5.24M | 3.0% | 0.47% | New | Sep 30, 2026 |
| Absci Corporation NASDAQ:ABSI | 479K | US$5.16M | 0.28% | 0.46% | −416K | Sep 30, 2026 |
| Oruka Therapeutics, Inc. NASDAQ:ORKA | 53,221 | US$4.43M | 0.40% | −59,967 | Sep 30, 2026 | |
| Avita Medical, Inc. NASDAQ:RCEL | 351K | US$4.11M | 1.1% | 0.37% | New | Sep 30, 2026 |
| OmniAb, Inc. NASDAQ:OABI | 726K | US$3.6M | 0.50% | 0.32% | New | Sep 30, 2026 |
| Erasca, Inc. NASDAQ:ERAS | 232K | US$3.39M | 0.07% | 0.31% | −27,173 | Sep 30, 2026 |
| Upstream Bio, Inc. NASDAQ:UPB | 618K | US$3.26M | 1.1% | 0.29% | −317K | Sep 30, 2026 |
| OptimizeRx Corporation NASDAQ:OPRX | 381K | US$3.18M | 2.0% | 0.29% | +31,006 | Sep 30, 2026 |
| Alphatec Holdings, Inc. NASDAQ:ATEC | 289K | US$2.99M | 0.19% | 0.27% | −161K | Sep 30, 2026 |
| OrthoPediatrics Corp. NASDAQ:KIDS | 125K | US$2.79M | 0.48% | 0.25% | New | Sep 30, 2026 |
| Inventiva SA EURONEXT:IVA | 651K | US$2.4M | 0.22% | New | Sep 30, 2026 | |
| Artivion, Inc. NYSE:AORT | 101K | US$2.31M | 0.21% | 0.21% | −37,610 | Sep 30, 2026 |
| Apnimed, Inc. NASDAQ:APMD | 105K | US$2.31M | 0.25% | 0.21% | New | Sep 30, 2026 |
| Disc Medicine, Inc. NASDAQ:IRON | 35,000 | US$2.29M | 0.08% | 0.21% | New | Sep 30, 2026 |
| Edap Tms SA NASDAQ:FOCL | 492K | US$2.2M | 1.3% | 0.20% | New | Sep 30, 2026 |
| Annexon, Inc. NASDAQ:ANNX | 498K | US$2.11M | 0.19% | −143K | Sep 30, 2026 | |
| Aligos Therapeutics, Inc. NASDAQ:ALGS | 326K | US$1.83M | 6.0% | 0.17% | New | Sep 30, 2026 |
| Pulmonx Corporation NASDAQ:LUNG | 854K | US$1.63M | 2.0% | 0.15% | +207K | Sep 30, 2026 |
| InspireMD Inc. NASDAQ:NSPR | 2.42M | US$1.61M | 4.5% | 0.15% | No change | Sep 30, 2026 |
| EyePoint, Inc. NASDAQ:EYPT | 486K | US$1.59M | 0.43% | 0.14% | −802K | Sep 30, 2026 |
| Lumexa Imaging Holdings, Inc. NASDAQ:LMRI | 140K | US$1.44M | 0.15% | 0.13% | New | Sep 30, 2026 |
| Liquidia Corporation NASDAQ:LQDA | 35,000 | US$1.06M | 0.04% | 0.10% | New | Sep 30, 2026 |
| Lyell Immunopharma, Inc. NASDAQ:LYEL | 85,758 | US$840K | 0.35% | 0.08% | New | Sep 30, 2026 |
| Ovid Therapeutics Inc. NASDAQ:OVID | 215K | US$537K | 0.11% | 0.05% | +17,515 | Sep 30, 2026 |